Repos Pharma
2013
FOUNDED
PRIVATE
STATUS
Early Stage VC
LATEST DEAL TYPE
1
INVESTORS
Description
Operator of a drug research and development company designed to provide treatment for cancer. The company's drug research is focused on re-profiling known drugs for their efficiency in treating additional forms of cancer, enabling cancer patients to begin their treatment more quickly and result in a higher likelihood of a successful treatment.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
- Dag Hammarskjölds Väg 40 C
- 752 37 Uppsala
- Sweden
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Repos Pharma’s full profile, request a free trial.
Repos Pharma Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | Completed | Startup |
Repos Pharma Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Nxt2b | Venture Capital | Majority | 000 0000 | 000000 0 |
Repos Pharma Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Angelica Loskog | Nxt2b | Chairman | 000 0000 |